Lorlatinib-Induced Pulmonary Embolism in a Patient With an ALK-Positive NSCLC

Bibliographic Details
Main Authors:	Ryo Toyozawa, MD, Naoki Haratake, MD, PhD, Gouji Toyokawa, MD, PhD, Taichi Matsubara, MD, PhD, Shinkichi Takamori, MD, PhD, Naoko Miura, MD, Masafumi Yamaguchi, MD, PhD, Mitsuhiro Takenoyama, MD, PhD, Takashi Seto, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2020-06-01
Series:	JTO Clinical and Research Reports
Subjects:	Lorlatinib ALK NSCLC Pulmonary embolism Dyslipidemia Hypertriglyceridemia
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666364320300059

Similar Items